Catalyst Wire Dossier Catalyst Wire Dossier

rM28

rM28 bispecific antibody
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rM28, covering 2013-01-16 to 2013-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 [Phase 1, Phase 2]

See pricing